한글목차

췌장암 정밀의료 시장 규모는 최근 급성장하고 있습니다. 2025년 5억 8,000만 달러에서 2026년에는 6억 7,000만 달러에 이르고, CAGR 16.7%의 성장이 전망되고 있습니다. 지난 수년간의 성장에는 기존 치료의 낮은 생존율, 암 유전체학의 발전, 췌장암 발생률 증가, 종양학 연구 자금의 확대, 표적치료제의 초기 단계에서의 성공 등이 주요 요인으로 작용한 것으로 보입니다.

췌장암 정밀의료 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 12억 4,000만 달러에 이르고, CAGR은 16.6%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 정밀 종양학 도입 확대, 췌장암 연구에 대한 투자 증가, 진단 기술 발전, 면역치료제 파이프라인 확대, 동반진단 활용 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 유전체 및 분자 프로파일링의 활용 증가, 바이오마커 기반 치료법의 보급 확대, 표적치료제와 면역치료의 병용 확대, 액체생검검사의 활용 증가, 개인 맞춤형 치료 경로에 대한 관심 증가 등을 꼽을 수 있습니다.

췌장암 발병률 증가는 향후 몇 년간 췌장암 정밀의료 시장의 성장을 견인할 것으로 예측됩니다. 췌장암은 소화와 혈당 조절에 필수적인 장기인 췌장 조직에 발생하는 악성 종양입니다. 고령화, 비만, 당뇨, 흡연 등 위험요인 증가로 인해 발생률이 증가하는 추세입니다. 췌장암 정밀의료는 유전적, 분자적 정보를 기반으로 한 개인별 맞춤 치료 계획을 제공하여 암 관리를 지원하고, 치료 효과 향상과 부작용 감소를 도모합니다. 예를 들어, 2025년 2월 호주 정부 기관인 Cancer Australia가 발표한 자료에 따르면, 2024년 신규 췌장암 환자 수는 4,641명(남성 2,414명, 여성 2,227명)으로 2023년 3,968명보다 증가할 것으로 예상하고 있습니다. 이처럼 췌장암의 유병률 증가가 췌장암 정밀의료 시장의 성장을 가속하고 있습니다.

췌장암 정밀의료 시장의 주요 기업들은 정밀의료 도구 등 첨단 기술 개발에 집중하고 있습니다. 이를 통해 조기 발견의 정확도 향상, 정확한 종양 프로파일링 실현, 개인별 맞춤 치료 전략의 최적화를 통해 환자의 치료 결과를 향상시키는 것을 목표로 하고 있습니다. 정밀의료 도구는 개인의 고유한 생물학적 특성에 따라 질병을 정확하게 진단하고 치료할 수 있도록 설계된 전문 장비입니다. 예를 들어, 2024년 1월, 미국에 본사를 둔 병원 및 헬스케어 조직인 시더스 시나이(Cedars Sinai)는 주요 바이오마커를 식별하여 췌장암의 생존율을 보다 정확하게 예측하는 것을 목표로 하는 정밀의료 도구인 분자 트윈(Molecular Twin) 정밀 종양학 플랫폼을 발표했습니다. 발표했습니다. 이 플랫폼은 74명의 췌관선암 환자 74명의 혈액 및 조직 샘플을 분석하여 자원이 부족한 환경에서도 치료 방침 결정에 도움을 줄 수 있는 높은 가능성을 보여줌으로써, 보다 정확하고 접근하기 쉬운 정밀 종양학 접근법을 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Pancreatic cancer precision medicine is a specialized treatment approach that personalizes care for pancreatic cancer patients. It utilizes genetic and molecular information from the patient and their tumor to develop a tailored treatment plan. This strategy aims to improve patient outcomes by optimizing therapy, minimizing unnecessary treatments, and increasing the likelihood of successful interventions.

The main therapeutic approaches in pancreatic cancer precision medicine include targeted therapy, immunotherapy, chemotherapy-precision combinations, and others. Targeted therapy involves drugs designed to specifically act on genetic mutations, proteins, or other molecules that drive cancer growth and spread. These treatments are supported by diagnostic technologies such as genomic testing, molecular diagnostics, liquid biopsies, and biomarker-based companion diagnostics. These therapies and technologies are applied in settings including hospitals, specialty clinics, academic and research institutes, and diagnostic centers.

Tariffs have influenced the pancreatic cancer precision medicine market by increasing the cost of imported genomic testing kits, biologic drugs, and specialized diagnostic reagents used in personalized oncology care. These impacts are most evident in advanced oncology centers across North America, Europe, and Asia Pacific, where precision diagnostics and targeted therapies are widely adopted. Rising tariff related expenses have contributed to higher overall treatment costs and budget pressure for cancer care providers. This has influenced procurement decisions and access planning for precision medicine solutions. However, tariffs have encouraged regional diagnostic innovation, expanded local manufacturing of precision oncology tools, and strengthened long term supply resilience.

The pancreatic cancer precision medicine market research report is one of a series of new reports from The Business Research Company that provides pancreatic cancer precision medicine market statistics, including pancreatic cancer precision medicine industry global market size, regional shares, competitors with a pancreatic cancer precision medicine market share, detailed pancreatic cancer precision medicine market segments, market trends and opportunities, and any further data you may need to thrive in the pancreatic cancer precision medicine industry. This pancreatic cancer precision medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pancreatic cancer precision medicine market size has grown rapidly in recent years. It will grow from $0.58 billion in 2025 to $0.67 billion in 2026 at a compound annual growth rate (CAGR) of 16.7%. The growth in the historic period can be attributed to poor survival rates with conventional therapies, advancements in cancer genomics, increased pancreatic cancer incidence, expansion of oncology research funding, early success of targeted therapies.

The pancreatic cancer precision medicine market size is expected to see rapid growth in the next few years. It will grow to $1.24 billion in 2030 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to growth in precision oncology adoption, rising investment in pancreatic cancer research, advancements in diagnostic technologies, expansion of immunotherapy pipelines, increasing use of companion diagnostics. Major trends in the forecast period include increasing use of genomic and molecular profiling, growing adoption of biomarker-based therapies, expansion of targeted and immunotherapy combinations, rising use of liquid biopsy diagnostics, increasing focus on personalized treatment pathways.

The increasing prevalence of pancreatic cancer is expected to drive the growth of the pancreatic cancer precision medicine market in the coming years. Pancreatic cancer is a malignancy that originates in the tissues of the pancreas, an organ essential for digestion and blood sugar regulation. Its incidence is rising due to an aging population and the growing prevalence of risk factors such as obesity, diabetes, and smoking. Pancreatic cancer precision medicine supports cancer management by providing personalized treatment plans based on genetic and molecular information, improving treatment efficacy while reducing side effects. For example, in February 2025, Cancer Australia, an Australian government agency, reported 4,641 new pancreatic cancer cases in 2024-2,414 in males and 2,227 in females-up from 3,968 cases in 2023. Consequently, the rising prevalence of pancreatic cancer is fueling growth in the pancreatic cancer precision medicine market.

Leading companies in the pancreatic cancer precision medicine market are focusing on developing advanced technologies, such as precision medical tools, to improve early detection, enable accurate tumor profiling, and optimize personalized treatment strategies for better patient outcomes. A precision medical tool is a specialized device designed to diagnose and treat diseases accurately based on an individual's unique biology. For example, in January 2024, Cedars-Sinai, a U.S.-based hospital and healthcare organization, launched the Molecular Twin precision oncology platform, a precision medical tool aimed at better predicting pancreatic cancer survival by identifying key biomarkers. The platform demonstrates strong potential in guiding treatment decisions, even in resource-limited settings, by analyzing blood and tissue samples from 74 patients with pancreatic ductal adenocarcinoma to provide a more accurate and accessible approach to precision oncology.

In January 2024, Bristol Myers Squibb, a U.S.-based biopharmaceutical company developing and commercializing innovative medicines across oncology, immunology, cardiovascular, and other therapeutic areas, acquired Mirati Therapeutics for an undisclosed amount. Through this acquisition, Bristol Myers Squibb gained access to Mirati's targeted oncology assets, including the commercial KRAS G12C inhibitor Krazati (adagrasib) and a complementary pipeline of KRAS- and PRMT5-focused programs, thereby enhancing its precision oncology capabilities and strengthening its global oncology portfolio. Mirati Therapeutics is a U.S.-based commercial-stage biotechnology company specializing in targeted cancer therapeutics and recognized for its expertise in developing precision oncology programs for KRAS-mutant cancers.

Major companies operating in the pancreatic cancer precision medicine market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bristol-Myers Squibb Company, AstraZeneca Plc, Novartis AG, Amgen Inc., Eli Lilly and Company, Genentech Inc., Ipsen Pharma, Bayer AG, Thermo Fisher Scientific Inc., Illumina Inc., Guardant Health, Foundation Medicine Inc., Oncolytics Biotech Inc., Erytech Pharma, PharmaCyte Biotech Inc., Celgene Corporation, Natera Inc.

North America was the largest region in the pancreatic cancer precision medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pancreatic cancer precision medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pancreatic cancer precision medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pancreatic cancer precision medicine market includes revenues earned by entities by providing services such as personalized treatment planning, tumour molecular profiling, precision imaging and diagnostics, and targeted therapeutics. The market value includes the value of related goods sold by the service provider or included within the service offering. The pancreatic cancer precision medicine market consists of sales of genetic and biomarker testing kits, immunotherapy drugs, and personalized cancer vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pancreatic Cancer Precision Medicine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pancreatic cancer precision medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pancreatic cancer precision medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pancreatic cancer precision medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Therapeutic Approach: Targeted Therapy; Immunotherapy; Chemotherapy-Precision Combinations; Other Therapeutic Approaches
• 2) By Diagnostic Technology: Genomic Testing; Molecular Diagnostics; Liquid Biopsy; Biomarker-Based Companion Diagnostics; Other Diagnostic Technologies
• 3) By Application: Hospitals; Specialty Clinics; Academic And Research Institutes; Diagnostic Centers
• Subsegments:
• 1) By Targeted Therapy: Kinase Inhibitors; PARP Inhibitors
• 2) By Immunotherapy: Immune Checkpoint Inhibitors; Cancer Vaccines; Adoptive Cell Therapy
• 3) By Chemotherapy-Precision Combinations: Gemcitabine-Based Combinations; Fluorouracil-Based Combinations; Nab-Paclitaxel-Based Combinations
• 4) By Other Therapeutic Approaches: RNA-Based Therapies; Epigenetic Modulators; Antibody-Drug Conjugates (ADCs)
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bristol-Myers Squibb Company; AstraZeneca Plc; Novartis AG; Amgen Inc.; Eli Lilly and Company; Genentech Inc.; Ipsen Pharma; Bayer AG; Thermo Fisher Scientific Inc.; Illumina Inc.; Guardant Health; Foundation Medicine Inc.; Oncolytics Biotech Inc.; Erytech Pharma; PharmaCyte Biotech Inc.; Celgene Corporation; Natera Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Pancreatic Cancer Precision Medicine Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Pancreatic Cancer Precision Medicine Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Pancreatic Cancer Precision Medicine Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Pancreatic Cancer Precision Medicine Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Increasing Use Of Genomic And Molecular Profiling
  • 4.2.2 Growing Adoption Of Biomarker-Based Therapies
  • 4.2.3 Expansion Of Targeted And Immunotherapy Combinations
  • 4.2.4 Rising Use Of Liquid Biopsy Diagnostics
  • 4.2.5 Increasing Focus On Personalized Treatment Pathways

5. Pancreatic Cancer Precision Medicine Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Specialty Oncology Clinics
• 5.3 Academic And Research Institutes
• 5.4 Diagnostic Centers
• 5.5 Cancer Research Centers

6. Pancreatic Cancer Precision Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pancreatic Cancer Precision Medicine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Pancreatic Cancer Precision Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Pancreatic Cancer Precision Medicine Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Pancreatic Cancer Precision Medicine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Pancreatic Cancer Precision Medicine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pancreatic Cancer Precision Medicine Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pancreatic Cancer Precision Medicine Market Segmentation

• 9.1. Global Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Targeted Therapy, Immunotherapy, Chemotherapy-Precision Combinations, Other Therapeutic Approaches
• 9.2. Global Pancreatic Cancer Precision Medicine Market, Segmentation By Diagnostic Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Genomic Testing, Molecular Diagnostics, Liquid Biopsy, Biomarker-Based Companion Diagnostics, Other Diagnostic Technologies
• 9.3. Global Pancreatic Cancer Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Specialty Clinics, Academic And Research Institutes, Diagnostic Centers
• 9.4. Global Pancreatic Cancer Precision Medicine Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Kinase Inhibitors, PARP Inhibitors
• 9.5. Global Pancreatic Cancer Precision Medicine Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy
• 9.6. Global Pancreatic Cancer Precision Medicine Market, Sub-Segmentation Of Chemotherapy-Precision Combinations, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Gemcitabine-Based Combinations, Fluorouracil-Based Combinations, Nab-Paclitaxel-Based Combinations
• 9.7. Global Pancreatic Cancer Precision Medicine Market, Sub-Segmentation Of Other Therapeutic Approaches, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• RNA-Based Therapies, Epigenetic Modulators, Antibody-Drug Conjugates (ADCs)

10. Pancreatic Cancer Precision Medicine Market Regional And Country Analysis

• 10.1. Global Pancreatic Cancer Precision Medicine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Pancreatic Cancer Precision Medicine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pancreatic Cancer Precision Medicine Market

• 11.1. Asia-Pacific Pancreatic Cancer Precision Medicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pancreatic Cancer Precision Medicine Market

• 12.1. China Pancreatic Cancer Precision Medicine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pancreatic Cancer Precision Medicine Market

• 13.1. India Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pancreatic Cancer Precision Medicine Market

• 14.1. Japan Pancreatic Cancer Precision Medicine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pancreatic Cancer Precision Medicine Market

• 15.1. Australia Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pancreatic Cancer Precision Medicine Market

• 16.1. Indonesia Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pancreatic Cancer Precision Medicine Market

• 17.1. South Korea Pancreatic Cancer Precision Medicine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pancreatic Cancer Precision Medicine Market

• 18.1. Taiwan Pancreatic Cancer Precision Medicine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pancreatic Cancer Precision Medicine Market

• 19.1. South East Asia Pancreatic Cancer Precision Medicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pancreatic Cancer Precision Medicine Market

• 20.1. Western Europe Pancreatic Cancer Precision Medicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pancreatic Cancer Precision Medicine Market

• 21.1. UK Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pancreatic Cancer Precision Medicine Market

• 22.1. Germany Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pancreatic Cancer Precision Medicine Market

• 23.1. France Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pancreatic Cancer Precision Medicine Market

• 24.1. Italy Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pancreatic Cancer Precision Medicine Market

• 25.1. Spain Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pancreatic Cancer Precision Medicine Market

• 26.1. Eastern Europe Pancreatic Cancer Precision Medicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pancreatic Cancer Precision Medicine Market

• 27.1. Russia Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pancreatic Cancer Precision Medicine Market

• 28.1. North America Pancreatic Cancer Precision Medicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pancreatic Cancer Precision Medicine Market

• 29.1. USA Pancreatic Cancer Precision Medicine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pancreatic Cancer Precision Medicine Market

• 30.1. Canada Pancreatic Cancer Precision Medicine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pancreatic Cancer Precision Medicine Market

• 31.1. South America Pancreatic Cancer Precision Medicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pancreatic Cancer Precision Medicine Market

• 32.1. Brazil Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pancreatic Cancer Precision Medicine Market

• 33.1. Middle East Pancreatic Cancer Precision Medicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pancreatic Cancer Precision Medicine Market

• 34.1. Africa Pancreatic Cancer Precision Medicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Pancreatic Cancer Precision Medicine Market, Segmentation By Therapeutic Approach, Segmentation By Diagnostic Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pancreatic Cancer Precision Medicine Market Regulatory and Investment Landscape

36. Pancreatic Cancer Precision Medicine Market Competitive Landscape And Company Profiles

• 36.1. Pancreatic Cancer Precision Medicine Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Pancreatic Cancer Precision Medicine Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Pancreatic Cancer Precision Medicine Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

37. Pancreatic Cancer Precision Medicine Market Other Major And Innovative Companies

• Novartis AG, Amgen Inc., Eli Lilly and Company, Genentech Inc., Ipsen Pharma, Bayer AG, Thermo Fisher Scientific Inc., Illumina Inc., Guardant Health, Foundation Medicine Inc., Oncolytics Biotech Inc., Erytech Pharma, PharmaCyte Biotech Inc., Celgene Corporation, Natera Inc.

38. Global Pancreatic Cancer Precision Medicine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pancreatic Cancer Precision Medicine Market

40. Pancreatic Cancer Precision Medicine Market High Potential Countries, Segments and Strategies

• 40.1 Pancreatic Cancer Precision Medicine Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Pancreatic Cancer Precision Medicine Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Pancreatic Cancer Precision Medicine Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer